Search results for "Geriatrics gerontology"

showing 10 items of 41 documents

Physical Activity and Nutrition INfluences In ageing (PANINI): consortium mission statement

2018

First paragraph: Current demographic trends indicate that by the year 2020, almost one in five of the European population will be aged 65 years or over. Although life expectancy is increasing by 2 years per decade, the period of life spent in good health is not keeping pace and most Europeans spend their last decade in poor health. Consequently, there is an urgent need to understand how lifestyle factors can influence age-related changes from gene to society level and how they may be integrated into a net effect of healthy ageing. It is also crucial to develop and validate interventions and health policies to ensure that more of our older adults have a healthy and active later life. This is…

0301 basic medicineGerontologyAgingPhysical activitybiomarkkeritravinto03 medical and health sciencesJournal ArticleMedicineMission statementPoint of ViewNutritionHigh prevalencemonitieteisyysMultidisciplinarybusiness.industryGeriatrics gerontologyPhysical activityBiomarkermedicine.disease3. Good healthAgeing030104 developmental biologyikääntyminenAgeing; Biomarkers; Multidisciplinary; Nutrition; Physical activity; Standardised measuresAgeingSarcopeniaStandardised measuresGeriatrics and Gerontologybusinessravitsemusfyysinen aktiivisuusBiomarkersAging Clinical and Experimental Research
researchProduct

Genetics of exceptional longevity: possible role of GM allotypes

2018

NOT REQUESTED FOR COMMENTARIES

0301 basic medicinelcsh:Immunologic diseases. Allergymedicine.medical_specialtyAgingmedia_common.quotation_subjectImmunologyLongevityGenome-wide association studyClinical nutritionBiologylcsh:GeriatricsCase control studies03 medical and health sciencesCase control studies; GM allotypes; GWAS; Immune response; Longevity; Immunology; Aging0302 clinical medicinemedicineGWASCase control studieImmune responsemedia_commonGeneticsGM allotypeSettore MED/04 - Patologia GeneraleGeriatrics gerontologyPublic healthLongevitylcsh:RC952-954.6030104 developmental biologyCommentaryGM allotypesGm Allotypeslcsh:RC581-607030215 immunologyImmunity & Ageing : I & A
researchProduct

International conference on biomedical aspects of aging research December 10-13, 1997 Fondazione Cini, San Giorgio, Venezia, Italy

1998

0303 health sciences03 medical and health sciencesAging0302 clinical medicineGeriatrics gerontologybusiness.industryLibrary scienceMedicine030212 general & internal medicineGeriatrics and Gerontologybusiness030304 developmental biology
researchProduct

Consensus Document on substitution therapy with DHEA in the elderly

2006

AdultMaleAgingmedicine.medical_specialtyHormone Replacement TherapyAlternative medicineSocio-culturaleAdult; Aged; Aged 80 and over; Aging; Atherosclerosis; Bone Diseases Metabolic; Cognition Disorders; Dehydroepiandrosterone; Female; Hormone Replacement Therapy; Humans; Italy; Male; Middle Aged80 and overAdrenal insufficiencyHumansMedicineSubstitution therapyIntensive care medicineAgedAged 80 and overbusiness.industryGeriatrics gerontologyDehydroepiandrosteroneMiddle AgedAtherosclerosismedicine.diseaseConsensus Document elderly adrenal insufficiency adrenopause DHEA DHEAS DHEA substitution therapyBone Diseases MetabolicItalyPhysical therapyFemaleMetabolicBone DiseasesGeriatrics and GerontologyCognition DisordersbusinessAging Clinical and Experimental Research
researchProduct

Platelets, eicosanoids and aging.

1992

Aged 80 and overBlood Plateletsmedicine.medical_specialtyAgingPlatelet AggregationGeriatrics gerontologybusiness.industrymedicine.diseaseThrombosisEndocrinologyInternal medicinemedicineBlood VesselsEicosanoidsHumansPlateletGeriatrics and GerontologybusinessAgedAging (Milan, Italy)
researchProduct

Pro-inflammatory status is not a limit for longevity: case report of a Sicilian centenarian

2020

Most studies on centenarians represent them as the best model of ageing. They are defined “delayers”, if they exhibit age-related diseases between 80 and 99 years, “survivors” if they show clinically demonstrable diseases before the age of 80 years, and “escapers” when they attain their 100th year of life without any common age-associated pathologies.

Aged 80 and overGerontologySettore MED/04 - Patologia GeneraleAgingGeriatrics gerontologymedia_common.quotation_subjectLongevityLongevityBiologylanguage.human_languageCase-Control StudieslanguageHumansLimit (mathematics)Geriatrics and GerontologyCentenarianSicilianCentenarian inflammation miRNAmedia_common
researchProduct

2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.

2021

Abstract Aim The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) algorithm for the management of knee osteoarthritis (OA) is available worldwide from 2014, but in 2019 an update was published. Based on this algorithm, a Working Group (WG), including ESCEO members and Chinese experts, wished to see how the new ESCEO algorithm was perceived by Chinese experts in knee OA and how it was integrated into their clinical practice. Methods A WG was held between members of the international ESCEO task force and a group of Chinese experts. Results Non-pharmacological approach should be combined with pharmacological interventions. …

AgingChinaSymptomatic slow-acting drugs for osteoarthritisOsteoarthritis03 medical and health sciences0302 clinical medicineMedicineHumans030212 general & internal medicineKnee osteoartrhitis · Patented crystalline glucosamine sulfate · Symptomatic slow-acting drugs for osteoarthritis · Algorithm · ChinaConsensus Document030203 arthritis & rheumatologyGlucosamineKnee osteoartrhitisbusiness.industryGeriatrics gerontologyTask forceAnti-Inflammatory Agents Non-SteroidalChondroitin SulfatesPatented crystalline glucosamine sulfateOsteoarthritis Kneemedicine.diseaseClinical PracticeAlgorithmPharmacological interventionsGeriatrics and GerontologybusinessAlgorithmAlgorithmsAging clinical and experimental research
researchProduct

Immunological and immunogenetic markers in sporadic Alzheimer’s disease

2006

Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

AgingDiseaseImmunogeneticsDiagnostic toolsProteomicsPathogenesisApolipoproteins EAlzheimer DiseaseHumansMedicineOligonucleotide Array Sequence AnalysisInflammationAlzheimer’s disease cytokines immunogenetics inflammation proteomicsPolymorphism GeneticGeriatrics gerontologybusiness.industryDNARisk evaluationGene Expression RegulationPositron-Emission TomographyImmunologyCytokinesMicrogliaGeriatrics and GerontologybusinessBiomarkersAcute-Phase ProteinsAging Clinical and Experimental Research
researchProduct

The Evergreen Project: Introduction

2003

AgingGeriatrics gerontologyLibrary scienceHealth ServicesEvergreenCohort StudiesInterviews as TopicGeographyHumansProspective StudiesGeriatrics and GerontologyEpidemiologic MethodsLife StyleFinlandAgedAging Clinical and Experimental Research
researchProduct

Erratum to: The burden of previuos fractures in hip fracture patients. The Break Study

2011

Agingmedicine.medical_specialtyHip fracturebusiness.industryGeriatrics gerontologyPhysical therapyMedicineGeriatrics and Gerontologybusinessmedicine.diseaseAging Clinical and Experimental Research
researchProduct